Cancer Research and Treatment

所属栏目:SCI期刊 热度:203

Cancer Research and Treatment

Cancer Research and Treatment

研究方向:医学
影响因子:3.363
官网:http://e-crt.org/
投稿地址:http://journal.cancer.or.kr/submission/Login.html
审稿速度:>12周,或约稿

  中文简介

《癌症研究与治疗》是韩国癌症协会的一份同行评审的开放访问出版物。每季度出版一期,每年出版一册。简称为癌症治疗。它接受与实验和临床癌症研究相关的手稿。受试者包括致癌、肿瘤生物学、分子肿瘤学、癌症遗传学、肿瘤免疫学、流行病学、预测标志物和癌症预防、病理学、癌症诊断、筛查和治疗,包括化疗、手术、放射治疗、免疫治疗、基因治疗、多模态治疗和姑息治疗。癌症研究与治疗(CRT)由SCI、MEDLine、PubMed、PubMed Central、Koreamed、CrossRef、Chemical Abstracts Service(CAS)、Scopus、Komci和Google Scholar编制索引/跟踪/覆盖。

  英文简介

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org) is an Open Access, peer-reviewed journal, published by AME Publishing Company, publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. TCR will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving cancer patients lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles. The Official Publication of Society for Translational Cancer Research (STCR),Hong Kong

  近年期刊自引率趋势图

  JCR分区

JCR分区等级 JCR所属学科 分区 影响因子
Q2 ONCOLOGY Q2 5.036

  近年期刊影响因子趋势图

  CiteScore数值

CiteScore SJR SNIP 学科类别 分区 排名 百分位
8.70 1.359 1.720 大类:Medicine 小类:Oncology Q1 56 / 360

84%

大类:Medicine 小类:Cancer Research Q2 54 / 210

74%

  相关医学SCI期刊推荐

SCI服务

搜论文知识网的海量职称论文范文仅供广大读者免费阅读使用! 冀ICP备15021333号-3